High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease

Because of its potent immunosuppressive yet stem cell–sparing activity, high-dose cyclophosphamide was tested as sole prophylaxis of graft-versus-host disease (GVHD) after myeloablative allogeneic bone marrow transplantation (alloBMT). We treated 117 patients (median age, 50 years; range, 21-66 year...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Luznik, Leo, Bolaños-Meade, Javier, Zahurak, Marianna, Chen, Allen R., Smith, B. Douglas, Brodsky, Robert, Huff, Carol Ann, Borrello, Ivan, Matsui, William, Powell, Jonathan D., Kasamon, Yvette, Goodman, Steven N., Hess, Allan, Levitsky, Hyam I., Ambinder, Richard F., Jones, Richard J., Fuchs, Ephraim J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2010
Gaiak:
Clinical Trials and Observations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2858487/
https://ncbi.nlm.nih.gov/pubmed/20124511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-11-251595
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak